Announcement on Progress of Litigation Enforcement by Subsidiaries (II)
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Progress of Litigation Enforcement by Subsidiaries (II)
Filed with SSE · · 1 page · Chinese
Release
Kangmei Pharmaceutical Co., Ltd on 6ix
Earlier from Kangmei Pharmaceutical
- Announcement on Progress of Litigation Enforcement by Subsidiaries
- Announcement on Expected Gains in Semi-annual Performance for 2024
- Announcement on the Removal of Other Risk Warnings for the Stock and Suspension of Trading
- Announcement on Resolutions of 3rd Special Session of 9th Board of Directors of 2024
- Announcement on Reply to "Letter of Supervision on Information Disclosure of 2023 Annual Report of Kangmei Pharmaceutical Co.,Ltd" from SSE
Later from Kangmei Pharmaceutical
- Announcement on Resolution of the 6th Meeting of 9th Board of Supervisors
- Announcement on Convening the 2024 Semi-annual Performance Briefing
- Announcement on Progress of Litigation Enforcement by Subsidiaries (III)
- Announcement on Resolutions of the 3rd Extraordinary Meeting of the 9th Board of Supervisors in 2024
- Announcement on Convening the Q3 2024 Performance Briefing
Follow Kangmei Pharmaceutical into a list and get an email when it puts out news.
Follow Kangmei Pharmaceutical